ASP1951
ASP1951 (PTZ-522) is a monoclonal antibody that targets GITR and is a GITR agonist. ASP1951 can be used for the research of advanced solid tumours.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human
TNFRSF18/GITR/CD357
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Synonyms
PTZ-522
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Davar D, et al. Targeting GITR in cancer immunotherapy - there is no perfect knowledge. Oncotarget. 2023;14:614-621. Published 2023 Jun 19. [Content Brief]
[2]. Buzzatti G, et al. New emerging targets in cancer immunotherapy: the role of GITR. ESMO Open. 2020 Aug;4(Suppl 3):e000738. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)